Bruker Corp

Bruker Corp

BRKR

Get informed when a big investor buys or sells

+ Follow
Market Cap$8.78B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bruker CorpBruker Corp-82.50.35%-3%2.61
$53.83

Target Price by Analysts

7.1% downsideBruker Target Price DetailsTarget Price
$10.94

Current Fair Value

81.1% downside

Overvalued by 81.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$8.78 Billion
Enterprise Value$10.96 Billion
Dividend Yield$0.20 (0.35%)
Earnings per Share$-0.15
Beta1.28
Outstanding Shares152,200,000

Return

Return on Equity-2.97%ROE
Return on Assets-1.18%
Return on Invested Capital0.51%

Valuation & Multiples

P/E Ratio-82.55P/E Ratio
PEG10.53PEG
Price to Sales2.63Price to Sales
Price to Book Ratio3.86Price to Book Ratio
Enterprise Value to Revenue3.13
Enterprise Value to EBIT447.3
Enterprise Value to Net Income-154
Total Debt to Enterprise0.22
Debt to Equity0.98Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 4, 2026
EPS Estimate
$0.38
Average shareholder expectation
Revenue Estimate
$853.57 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 2, 2026
EPS Estimate
$0.42
Average shareholder expectation
Revenue Estimate
$867.35 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.1579 61.97%
Total Calls5,700 97.37%
Total Puts900 99.47%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %21.75% 68.44%
Total Invested$1.95B 60.57%
Investors Holding181 169.00%

ESG Score

No data

About Bruker Corp

6,000 employees
CEO: Frank Laukien

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...